Transthyretin-related Amyloidosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-01-23
Clinical Trial Update: Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy [Phase 2, Phase 3]
Phase 2/3 trial results summarize efficacy and safety of inotersen for familial amyloid polyneuropathy (FAP).